1. Home
  2. CAPR vs NGVC Comparison

CAPR vs NGVC Comparison

Compare CAPR & NGVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CAPR
  • NGVC
  • Stock Information
  • Founded
  • CAPR 2005
  • NGVC 1955
  • Country
  • CAPR United States
  • NGVC United States
  • Employees
  • CAPR N/A
  • NGVC N/A
  • Industry
  • CAPR Biotechnology: Biological Products (No Diagnostic Substances)
  • NGVC Food Chains
  • Sector
  • CAPR Health Care
  • NGVC Consumer Staples
  • Exchange
  • CAPR Nasdaq
  • NGVC Nasdaq
  • Market Cap
  • CAPR 600.7M
  • NGVC 1.1B
  • IPO Year
  • CAPR N/A
  • NGVC 2012
  • Fundamental
  • Price
  • CAPR $10.00
  • NGVC $39.07
  • Analyst Decision
  • CAPR Strong Buy
  • NGVC
  • Analyst Count
  • CAPR 8
  • NGVC 0
  • Target Price
  • CAPR $33.75
  • NGVC N/A
  • AVG Volume (30 Days)
  • CAPR 3.3M
  • NGVC 304.5K
  • Earning Date
  • CAPR 08-06-2025
  • NGVC 08-07-2025
  • Dividend Yield
  • CAPR N/A
  • NGVC 1.22%
  • EPS Growth
  • CAPR N/A
  • NGVC 42.37
  • EPS
  • CAPR N/A
  • NGVC 1.78
  • Revenue
  • CAPR $17,363,588.00
  • NGVC $1,297,733,000.00
  • Revenue This Year
  • CAPR $258.96
  • NGVC $1.32
  • Revenue Next Year
  • CAPR $8.02
  • NGVC N/A
  • P/E Ratio
  • CAPR N/A
  • NGVC $22.03
  • Revenue Growth
  • CAPR N/A
  • NGVC 9.36
  • 52 Week Low
  • CAPR $3.52
  • NGVC $20.91
  • 52 Week High
  • CAPR $23.40
  • NGVC $61.22
  • Technical
  • Relative Strength Index (RSI)
  • CAPR 46.79
  • NGVC 38.61
  • Support Level
  • CAPR $6.07
  • NGVC $35.87
  • Resistance Level
  • CAPR $13.51
  • NGVC $44.50
  • Average True Range (ATR)
  • CAPR 1.67
  • NGVC 2.27
  • MACD
  • CAPR -0.38
  • NGVC -0.37
  • Stochastic Oscillator
  • CAPR 46.02
  • NGVC 36.00

About CAPR Capricor Therapeutics Inc.

Capricor Therapeutics Inc is a clinical-stage biotechnology company focused on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (DMD), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with high unmet medical needs. The company's product pipeline includes CAP-1002, deramiocel an allogeneic cardiac-derived cell therapy. Deramiocel is currently advancing through Phase 3 clinical development for the treatment of Duchenne muscular dystrophy. Through its proprietary StealthXTM platform, the group uses its exosome technology to conduct preclinical research focused on vaccinology, delivering oligonucleotides, proteins, and small molecules to treat.

About NGVC Natural Grocers by Vitamin Cottage Inc.

Natural Grocers by Vitamin Cottage Inc operates natural and organic grocery and dietary supplement stores. It offers the following product categories, natural and organic food, dietary supplements, natural body care, household, pet care products, books and handouts. The Company has a single reporting segment, natural and organic retail stores, through which business are conducted. The company generates the majority of its revenue from grocery products and dietary supplements and rest from other products.

Share on Social Networks: